TriCipher, a leading provider of Internet identity services, today announced a hosted, on-demand version of its powerful digital signature solution. myOneLogin SignatureBook is an on-demand service that accelerates and streamlines business processes requiring non-repudiable signatures across different groups, organizations or geographic locations. It supports a number of different online credentials, including a clientless credential and the SAFE-BioPharma digital signature widely adopted in healthcare and pharmaceutical industries.
“The SAFE-BioPharma® signature standard provides a high level of trust assurance for digital identities, and is instrumental to speeding processes and reducing costs in the healthcare and pharmaceutical industries,” said Mollie Shields-Uehling, president and CEO, SAFE-BioPharma Association. “The Tricipher myOneLogin SignatureBook service offers SAFE-BioPharma members a means of improving business process and simplifying the signing process. This service will be especially attractive to the growing body of smaller companies which have joined SAFE-BioPharma as a step toward improving their workflows and converting to paperless operations.”
myOneLogin SignatureBook collects digital signatures on an electronic document, automatically applying signature policies and streamlining processes of collecting and validating signatures. It creates an original, signed version of a final document as well as a flattened PDF without active signature blocks, suitable for distribution. As an on-demand service, myOneLogin SignatureBook is easy to deploy, and is particularly useful for organizations with many business processes requiring signatures by multiple parties. The service offers several different signature methods, including a TriCipher clientless credential and with credentials compliant with the SAFEBioPharma digital signature standard. myOneLogin SignatureBook is the in-the-cloud, hosted version of the on-premise TriCipher mySignatureBook digital signing solution.
“Digital signatures are a natural extension of the Internet identity services that we provide at TriCipher, making it easier and more secure to do business on the web,” said John De Santis, chairman and CEO at TriCipher. “The on-premise TriCipher mySignatureBook solution is already adopted in large pharmaceutical organizations. By offering these capabilities as an on-demand service, we deliver on the promise of digital signatures for a wider range of businesses.”
For more information, please visit www.myOneLogin.com.